Related Experiment Videos
Cardiovascular research support by the American Heart Association in Louisiana
1Cardiology Section at LSU School of Medicine in Shreveport, USA.
Insights
The American Heart Association funds vital cardiovascular research, leading to breakthroughs in treatments and diagnostics. Their support has fostered scientific careers and improved heart disease care.
Area of Science:
- Cardiovascular Medicine
- Medical Research Funding
Background:
- Founded in 1924 by physician-scientists due to frustrations in heart disease treatment.
- Evolved mission includes education and community service, with research support as a core focus.
Purpose of the Study:
- To highlight the American Heart Association's historical and ongoing role in advancing cardiovascular medicine.
- To underscore the impact of AHA-funded research on medical breakthroughs and career development.
Main Methods:
- Review of the American Heart Association's historical contributions and funding initiatives.
- Analysis of research advancements attributed to AHA support.
Main Results:
- AHA funding has driven major cardiovascular medicine advances, including pacemakers and defibrillators.
- Nearly $1.4 billion distributed for research, supporting numerous investigators and four Nobel laureates.
- Continued support for diagnosis and treatment of cardiovascular disease, America's leading cause of death.
Conclusions:
- The American Heart Association remains central to progress in cardiovascular research and treatment.
- Sustained funding by the AHA is critical for addressing cardiovascular disease challenges.
Abstract:
The American Heart Association (AHA) was founded in 1924 by a group of physician-scientists to promote the exchange of research ideas in an era when the treatment of heart disease was extremely frustrating. The organization has evolved to include education and community service in its mission, but the support and promotion of quality research has remained at the AHA's core. Research support by the AHA has been responsible for major advances in cardiovascular medicine, including the development of diuretics, pacemakers, artificial heart valves, defibrillators, cardiopulmonary resuscitation, hypercholesterolemia therapy, and artificial surfactant. Working to ensure the efficient distribution of funds, the AHA has distributed nearly $1.4 billion in support of quality research for graduate and medical students, post-doctoral fellows, and beginning and established investigators. Such support has assisted in the career development of four Nobel Prize winners. While cardiovascular disease remains America's leading cause of death, the activities of the AHA continue to support advances in its diagnosis and treatment.